The Impact of a Topical Vasodilating Cream on Female Sexual Experience (TVConFSD)
This study is currently recruiting participants.
Verified March 2012 by East Suburban Ob Gyn
Sponsor:
Michael Pelekanos MD
Collaborator:
West Penn Allegheny Health System
Information provided by (Responsible Party):
Michael Pelekanos MD, East Suburban Ob Gyn
ClinicalTrials.gov Identifier:
NCT01078077
First received: March 1, 2010
Last updated: March 1, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.
| Condition |
|---|
|
Female Sexual Dysfunction |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | The Impact of a Topical Vasodilating Cream (When Applied to the Clitoris) on the Female Sexual Experience Using a Standard 7 Part Female Sexual Dysfunction Questionnaire |
Further study details as provided by East Suburban Ob Gyn:
| Estimated Enrollment: | 200 |
| Study Start Date: | March 2010 |
| Estimated Study Completion Date: | July 2012 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |
To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire
Eligibility| Ages Eligible for Study: | 25 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Sexually active females from ages 25 to sixty not on SSRI's without neurologic disease able sign and understand informed consent
Criteria
Inclusion Criteria:
- Healthy females ages 25 to sixty sexually active
Exclusion Criteria:
- Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01078077
Contacts
| Contact: michael j pelekanos, MD | 4128567500 | mipels@aol.com |
| Contact: Guy Stofman, MD | 4123706313 | guystof@aol.com |
Locations
| United States, Pennsylvania | |
| West Penn Allegheny Health Center | Recruiting |
| Monroeville, Pennsylvania, United States, 15146 | |
| Contact: pelekanos 412-856-7500 | |
| Contact: vickie lathom 4128567500 | |
| Principal Investigator: michael j pelekanos, md | |
| West Penn Hospital Forbes Campus | Recruiting |
| Monroeville, Pennsylvania, United States, 15146 | |
| Contact: michael j pelekanos, md 412-856-7500 mipels@aol.com | |
| Principal Investigator: michael j pelekanos, md | |
| East Suburban Obgyn | Recruiting |
| Monroeville, Pennsylvania, United States, 15146 | |
| Contact: Michael J Pelekanos, MD 412-779-1034 mipels@aol.com | |
| Contact: Guy Stoffman, MD 412 3706313 guystof@aol.com | |
| Principal Investigator: Michael J Pelekanos, MD | |
Sponsors and Collaborators
Michael Pelekanos MD
West Penn Allegheny Health System
Investigators
| Principal Investigator: | michael j pelekanos, MD | east surburban obgyn |
More Information
No publications provided
| Responsible Party: | Michael Pelekanos MD, michael pelekanos MD, WPAHS, East Suburban Ob Gyn |
| ClinicalTrials.gov Identifier: | NCT01078077 History of Changes |
| Other Study ID Numbers: | 10-005 |
| Study First Received: | March 1, 2010 |
| Last Updated: | March 1, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by East Suburban Ob Gyn:
|
healthy females ages twentyfive through sixty |
Additional relevant MeSH terms:
|
Sexual Dysfunctions, Psychological Sexual and Gender Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 18, 2013